Frequently asked questions.

WGS reads all 6.4 billion base pairs and every gene region. Dante performs clinical-grade 30X whole genome sequencing, the gold standard for variant identification, unlike targeted tests that check only pre-selected markers.

Consumer tests use genotyping, reading less than 0.02% of your genome. Dante sequences the full genome at 30X clinical coverage, identifying 4.6–5 million variants including rare variants and structural changes.

30X coverage means that, on average, every position in your genome is read 30 times. This ensures 99.98% accuracy and is the clinical diagnostic standard.

810+ physician-ready reports cover cardiac conditions, hereditary cancer, neurological conditions, rare diseases, and pharmacogenomics, delivered through the Genome Manager portal.

Yes. While your DNA doesn’t change, new variant-disease associations are discovered monthly. Dante validates findings and updates reports automatically; you can add new reports without resampling.

Yes. Existing data from 23andMe, AncestryDNA, or similar providers can be uploaded to access Dante’s clinical-grade reports and interpretation.

Yes. Shared DNA means results provide insights for biological relatives regarding heritable conditions like hereditary cancer or cardiac disease affecting parents, siblings, and children.

No. WES reads only protein-coding regions (1–2% of DNA). WGS reads all 6.4 billion base pairs including regulatory and intergenic regions, making it more comprehensive.

Reports deliver to your secure Genome Manager portal for viewing, downloading, and sharing with doctors. Raw data files (FASTQ, BAM, VCF) are available upon request.

Dante’s proprietary platform provides complete genome data access, includes AI Genome Chat for plain-language questions, physician-ready outputs, family profiles, and clinical team sharing capabilities.

Yes. Reports are designed to be physician-ready — formatted for clinical review, shareable directly from your account or downloadable for appointments. NHS hospitals have reviewed and accepted results.

Share results with your doctor or genetic counselor. Reports use ACMG guidelines (the standard for clinical geneticists) to inform next steps including testing, screening, or care plan changes.

You do. You control your data—download, delete, or anonymize anytime. Dante doesn’t sell personal information or genomic data.

No. Data is never sold or shared without explicit consent. Dante operates as Data Controller under GDPR.

Samples are destroyed after results become available in your account. Results remain until account deactivation; personal data is retained 10 years for legal compliance only.

Yes. Dante Labs S.r.l. operates as Data Controller under GDPR, with all activity within EU and US. Processing follows GDPR regulations; data is never shared or sold.

Two things. First, we read your complete genetic code — the set of instructions you were born with. This reveals predispositions and risks that never change. Then, twice a year, an RNA test measures your cellular activity — what your body is actually doing with those instructions right now. Together, they give you the full picture.

Standard blood tests measure the outputs of biological processes — things like cholesterol levels, hormone levels, and protein markers. By the time those numbers shift, the underlying process has been running for weeks or months. We measure at the cellular level, catching signals upstream — before they show up on a standard panel.

A simple card with a small lancet. You prick your finger, apply a few drops of blood to the card, let it dry, and mail it back in the prepaid envelope. Takes about two minutes. No clinic visit needed.

Not at all. Your reports are written in plain language with clear explanations. If you want to share them with a doctor, they’re also designed to be physician-ready.

Yes. You can share access through your portal or download reports to bring to appointments.

Yes, anytime. Your data and all reports remain yours. Full access to everything, downloadable at any time.